First Header Logo Second Header Logo

Connection

Yaron Barac to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Yaron Barac has written about Dose-Response Relationship, Drug.
Yaron Barac
Connection Strength
0.086
Dose-Response Relationship, Drug
  1. Barac YD, Bar-Am O, Liani E, Amit T, Frolov L, Ovcharenko E, Angel I, Youdim MB, Binah O. I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline. PLoS One. 2012; 7(11):e47890.
    View in: PubMed
    Score: 0.086
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.